Robert V. Campos

$256,531.19asSenior Director

Employed by Ontario Institute For Cancer Research in 2025, according to Government of Ontario public salary records.

Salary Information

Historical salary and taxable benefits from 2017 to 2025.

YearPositionSalaryBenefitsPerformance
2025
Senior Director
$256,531.19
$1,430.16
2.31%
2024
Senior Director
$262,584.41
$1,400.64
1.76%
2023
Senior Director
$267,299.93
$1,380.99
8.03%
2021
Senior Director
$247,426.16
$1,244.16
1.89%
2019
Head, Research Operations
$242,832.90
$1,218.24
3.3%
2018
Head, Research Operations
$251,128.80
$1,218.24
3.05%
2017
Head, Research Operations and Director, Genomics
$259,040.31
$1,140.32

The Ontario Sunshine List reports that Robert V. Campos was paid $256,531.19 in 2025 as Senior Director at Ontario Institute For Cancer Research. This represents a 2.31% decrease from the previous year's reported salary. Robert V. Campos has appeared on the Ontario Sunshine List 7 times between 2017 and 2025, with reported earnings peaking at $267,299.93 in 2023. In addition to salary, $1,430.16 in taxable benefits was disclosed for 2025. Ontario Institute For Cancer Research reports under the Other Public Sector Employers sector of Ontario's public sector salary disclosure.

Top earning Senior Directors in Ontario Institute For Cancer Research

NameSalary
Robert V. Campos$256,531.19
David M Sutton$240,445.77
Patricia Michelle Douglas-Prashad$228,129.82
Howard Simkevitz$223,107.92
Donna Mckenzie$222,020.20
Melanie Courtot$217,597.09

Top earning Senior Directors in Ontario

NameSalary
Regional Municipality Of Peel Police Services
$275,255.83
University Health Network
$268,934.82
University Health Network
$268,635.03
Regional Municipality Of Peel Police Services
$258,622.69
Regional Municipality Of Peel Police Services
$241,153.53
London Health Sciences Centre
$222,568.12
University Health Network
$221,398.56
Lakeridge Health
$220,090.66
University Health Network
$219,257.54
Lakeridge Health
$212,902.42
NameSalary
Lincoln Stein
Acting Scientific Director and Head, Adaptive Oncology
$383,286.80
Jared T. Simpson
Interim Scientific Director and Principal Investigator
$331,897.15
David E. Uehling
Interim Scientific Director, Therapeutic Innovation and Drug Discovery
$329,520.45
Peter Goodhand
Executive Lead
$321,484.80
Jeanette Dias D'Souza
Senior Vice President, Group Chief Financial Officer
$319,995.00
Rebecca L. Tamarchak
Head, Strategy, Governance and Partnerships
$249,995.20
David M Sutton
Senior Director
$240,445.77
Juri Reimand
Principal Investigator
$233,643.01
Methvin Isaac
Senior Scientific Advisor
$229,139.58
Patricia Michelle Douglas-Prashad
Senior Director
$228,129.82